-+ 0.00%
-+ 0.00%
-+ 0.00%

CRINETICS PHARMACEUTICALS INC : UBS CUTS TO NEUTRAL FROM BUY; CUTS TARGET PRICE TO $85 FROM $55

Reuters·07/28/2026 14:11:24

Please log in to view news